Synthesis and biological evaluation of potent αvβ3-integrin receptor antagonists
- 30 November 2006
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 33 (8) , 953-961
- https://doi.org/10.1016/j.nucmedbio.2006.08.008
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Improvement of Pharmacokinetics of Radioiodinated Tyr3-Octreotide by Conjugation with CarbohydratesBioconjugate Chemistry, 2002
- Selective α v β 3 -Receptor Blockade Reduces Macrophage Infiltration and Restenosis After Balloon Angioplasty in the Atherosclerotic RabbitCirculation, 2001
- Bone Resorption by OsteoclastsScience, 2000
- The role of αv integrins during angiogenesis: insights into potential mechanisms of action and clinical developmentJournal of Clinical Investigation, 1999
- Decreased angiogenesis and arthritic disease in rabbits treated with an αvβ3 antagonistJournal of Clinical Investigation, 1999
- Recent insights into the role of integrins in cancer metastasisCellular and Molecular Life Sciences, 1998
- Stereoisomeric Peptide Libraries and Peptidomimetics for Designing Selective Inhibitors of the αvβ3 Integrin for a New Cancer TherapyAngewandte Chemie International Edition in English, 1997
- Conformation/activity studies of rationally designed potent anti‐adhesive RGD peptidesEuropean Journal of Biochemistry, 1992
- Arg‐Gly‐Asp constrained within cyclic pentapoptides Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1FEBS Letters, 1991
- New Perspectives in Cell Adhesion: RGD and IntegrinsScience, 1987